Researchers conducted a meta-analysis, looking at 13 studies with about 700 participants in total with pulmonary hypertension (PH). They found that exercise improved 6-minute walk distance and was consistently well-tolerated by PH patients, and there were no serious adverse events directly linked to the exercise activities in the studies. Read the European Journal of Applied Physiology article

A study found that chronic thromboembolic pulmonary hypertensio (CTEPH) patients had significantly more of an antioxidant enzyme (peroxiredoxin 2, or PRDX2) in their bloodstream compared to healthy patients. Using rats, the researchers determined that PRDX2 helped reduce inflammation, suggesting that it has a protective role and might have therapeutic use. Read the Scientific Reports article

This study examined the causes of delayed diagnosis (diagnosis after approximately 22 months) of pulmonary arterial hypertension (PAH) and whether an earlier diagnosis (within six months) leads to better outcomes. They identified several factors associated with delayed diagnosis and found that earlier diagnosis and treatment were associated with better survival. Read the Pulmonary Circulation article